A leading BioPharma company, renowned for its innovative therapies and extensive research, was grappling with the complexities of managing a diverse array of business applications and operational processes. The company faced substantial operational costs, inefficiencies in support functions, and a significant talent gap in handling advanced automation technologies. These challenges were hindering their ability to maintain high standards of service and operational efficiency.

• Operational Inefficiencies: The company’s existing support structure was disjointed and inefficient. This fragmentation led to delays and inconsistencies in resolving technical issues, adversely impacting business continuity and performance.
• High Costs: The internal development and maintenance of custom automation solutions, along with the support team’s overhead, resulted in escalating costs. The financial burden was becoming unsustainable.
• Talent Shortage: Finding and retaining professionals with the requisite skills in AI and RPA (Robotic Process Automation) was proving difficult. This talent shortage meant that the company struggled to innovate and optimize its processes effectively.

• Airo Digital Labs as a digital transformation partner for Customer provided a holistic approach for transformation by co-creating RPA Factory with Governance, Adoption & employee Upskilling.
• We quickly deployed a dedicated team of various skills, such as, RPA Factory leader, RPA & AI solution architects, Data Engineer, and Business analysts.
• We leveraged various Intelligent Automation tools to automate multiple business processes and built 75+ bots across IT, F&A, HR, Manufacturing, Supply Chain, EBR processing, and Genomic Data analysis).
• We also implemented Gen AI based Website Chatbot deployment for product, HR and IT helpdesk leveraging OpenAI LLM.

The implementation of Airo’s solutions led to remarkable improvements and substantial cost savings for the BioPharma company:

• Supercharged Efficiency and Cost Savings: Achieved a 40% reduction in overall operational costs within the first year, followed by a further 58% cost reduction across multiple business processes. This translates to significant savings that can be reinvested into critical areas like drug development, clinical trials, and manufacturing advancements.
• Unleashing Scientific Potential: Productivity soared by 3x, empowering scientists to dedicate more time to groundbreaking research and innovation. This can lead to faster drug discovery timelines, potentially bringing life-saving treatments to patients sooner.
• Streamlined Operations and Accelerated Timelines: The combined impact of cost savings and increased productivity fosters a more streamlined operational environment. This can potentially lead to faster completion of critical processes like clinical trials, ultimately accelerating the path to market for new drugs.
• Shop Floor Automation: Product packaging and shipment, AI chatbot based issue resolution improvement, product search, improved MTTR by 40%
• Introduced Airo’s proprietary AI and Automation upskilling platform (OMNI) for their employees to accelerate their RPA & AI journey.

This case study showcases how a leading BioPharma company transformed operations through AI and automation. Struggling with inefficiencies and high costs, they partnered with Airo for a holistic solution. Airo co-created an RPA Factory and deployed a skilled team, resulting in over 75 automated processes across various departments – even including Gen AI-powered chatbots. These advancements yielded significant benefits: a 40% initial cost reduction followed by an additional 58% in savings, a 3x boost in scientific productivity, and potentially faster drug development timelines. By empowering employees with Airo’s upskilling platform, the company is well-positioned for a future driven by innovation and efficiency.